Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11032733 | Journal of Pharmacological and Toxicological Methods | 2018 | 38 Pages |
Abstract
Given the lack of standard process and/or quality metrics in place for the use of stem cell-based products for in vitro testing per se, we discuss here the key elements that one needs to consider when designing, implementing and executing CTiD studies, in order to ensure an approach that will reliably mimic clinical trials, and allow obtaining reproducible and reliable experimental data.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Bernard Fermini, Kevin P. Coyne, Shawn T. Coyne,